Lucintel Forecasts Middle Eastern And North African Active Pharmaceutical Ingredient (api) Market To Reach $5 Billion By 2030

By Author: Lucintel LLC
Total Articles: 7912
Comment this article

According to the recent study the Middle Eastern and North African active pharmaceutical ingredient (API) market is projected to reach an estimated $5 billion by 2030 from $3 billion in 2023, at a CAGR of 4.7% from 2024 to 2030. Growth in this market is primarily driven by pharmaceutical production and research and development of new drugs.
Browse 97 figures/charts and 71 tables in this 158-page report to understand trends, opportunities and forecast in Middle Eastern and North African active pharmaceutical ingredient (API) market by synthesis type (synthetic chemical, biotech and biologics, plant extracts, fermentation, and others), manufacturer type (captive API and merchant API), therapeutic area (cardiology, oncology, neurology, ophthalmology, orthopedics, pulmonology, aliment, anti-inflammatory, and others), product form (liquid API and powder API), molecule type (large molecule and small molecule), and drug type (branded, generic, and over-the-counter).
Download report by clicking on Middle Eastern and North African active pharmaceutical ingredient (API) market
Lucintel forecasts that synthetic chemical ...
... will remain the largest segment over the forecast period due to continuous research and development activities and growing demand of synthetic chemical APIs in therapeutic areas.
Within this market, cardiology will remain the largest therapeutic area segment over the forecast period due to increasing cardiovascular diseases and increase in geriatric population.
Pfizer, Teva Pharmaceutical, GSK, Sun Pharmaceutical, Novartis, Aurobindo, Merck& Co., BASF, Julphar, and AbbVie are the major suppliers in the Middle Eastern and North African active pharmaceutical ingredient (API) providers.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest Publications
Naphthalene Water Reducer Market in Canada
N-Mdea Market in Canada
Plastic Straps Market in Canada
Precision Planetary Speed Reducer Market in Canada
Riveting Equipment Market in Canada
Sodium Hydrosulphide Market in Canada